Survey Report: Biosimilars in Alberta and BC
Survey Report: Biosimilars in Alberta and BC Four provinces across Canada have implemented non-medical switching (NMS) policies for biologic medications. In these jurisdictions, to maintain public coverage, individuals must switch from their originator biologic to a corresponding biosimilar. In May 2019, the government of British Columbia (BC) launched their NMS policy and Alberta followed shortly [...]